We are live on ! Find out more
FA

Fagan Associates Portfolio holdings

AUM $813M
1-Year Est. Return 37.92%
This Fund
S&P 500
This Quarter Est. Return
+3.86%
1 Year Est. Return
+37.92%
3 Year Est. Return
+110.01%
5 Year Est. Return
+134.08%
10 Year Est. Return
+585.67%
AUM
$223M
AUM Growth
-$11.8M
Cap. Flow
+$6.36M
Cap. Flow %
2.85%
Top 10 Hldgs %
37.57%
Holding
115
New
14
Increased
50
Reduced
38
Closed
4
Avg Time Held
9.5 quarters
Top 10 Avg Time Held
6.6 quarters
Top 20 Avg Time Held
9 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 19.92%
2 Technology 19.26%
3 Financials 15.44%
4 Consumer Discretionary 12.77%
5 Communication Services 12.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
XLI icon
101
State Street Industrial Select Sector SPDR ETF
XLI
$30.3B
$313K 0.14%
4,373
+796
+22% +$59K
2017 Q3
3 quarters
XLE icon
102
State Street Energy Select Sector SPDR ETF
XLE
$41.9B
$287K 0.13%
7,550
+452
+6% +$16.8K
2014 Q1
17 quarters
BAX icon
103
Baxter International
BAX
$12.6B
$273K 0.12%
3,700
-150
-4% -$10.6K
2017 Q2
4 quarters
BMY icon
104
Bristol-Myers Squibb
BMY
$121B
$243K 0.11%
4,385
-2,685
-38% -$145K
2016 Q4
6 quarters
XLF icon
105
State Street Financial Select Sector SPDR ETF
XLF
$50.9B
$236K 0.11%
+8,861
New +$244K
2018 Q2
0 quarters
SCHV icon
106
Schwab US Large-Cap Value ETF
SCHV
$15.4B
$235K 0.11%
+13,296
New +$237K
2018 Q2
0 quarters
CONE
107
DELISTED
CyrusOne Inc Common Stock
CONE
$234K 0.11%
+4,015
New +$218K
2018 Q2
0 quarters
SDY icon
108
State Street SPDR S&P Dividend ETF
SDY
$20.7B
$222K 0.1%
2,400
– –
2014 Q1
17 quarters
REGN icon
109
Regeneron Pharmaceuticals
REGN
$76.9B
$209K 0.09%
605
– –
2014 Q1
17 quarters
SCHX icon
110
Schwab US Large- Cap ETF
SCHX
$75.3B
$209K 0.09%
19,332
-60
-0.3% -$647
2017 Q4
2 quarters
EW icon
111
Edwards Lifesciences
EW
$49.1B
$201K 0.09%
+4,137
New +$193K
2018 Q2
0 quarters
BAB icon
112
Invesco Taxable Municipal Bond ETF
BAB
$838M
– –
-8,639
Closed -$260K –
DHI icon
113
D.R. Horton
DHI
$37.7B
– –
-5,270
Closed -$231K –
ORCL icon
114
Oracle
ORCL
$429B
– –
-33,211
Closed -$1.52M –
PSF icon
115
Cohen & Steers Select Preferred & Income Fund
PSF
$219M
– –
-9,975
Closed -$260K –

Similar funds

Fagan Associates's Q2 2018 Portfolio in Review

As of Q2 2018, Fagan Associates held 115 positions worth $223M, down 5% from $235M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Fagan Associates's Q2 2018 filing shows 14 new, 50 increased, 38 reduced and 4 closed positions. Its largest new stake was ProShares Investment Grade-Interest Rate Hedged: 13,276 shares worth $981K. The largest sale was Oracle, an estimated $1.52M.

By sector, the portfolio is most concentrated in Miscellaneous at 20% of assets, up from 18% a quarter earlier, followed by Technology and Financials.

  • Fagan Associates's largest Q2 2018 buy was ProShares Investment Grade-Interest Rate Hedged: 13,276 shares worth $981K.
  • Fagan Associates added most to Alphabet (Google) Class A in Q2 2018, an estimated $766K increase.
  • Fagan Associates's biggest Q2 2018 reduction was Micron Technology, cutting an estimated $1.04M.
  • Fagan Associates fully exited Oracle in Q2 2018, selling an estimated $1.52M.
  • Fagan Associates's ten largest holdings make up 38% of its $223M portfolio in Q2 2018.
  • Fagan Associates opened 14 new positions and closed 4 in Q2 2018.
  • Fagan Associates's portfolio value fell 5% quarter-over-quarter to $223M.

Based on Fagan Associates's 13F filing for Q2 2018, filed 6 Aug 2018.